Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Outlook Therapeutics (OTLK) Other Gross PP&E Adjustments (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Other Gross PP&E Adjustments for 8 consecutive years, with -$670807.0 as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 45.99% to -$670807.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$670807.0 through Dec 2025, up 45.99% year-over-year, with the annual reading at -$421131.0 for FY2025, N/A changed from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$670807.0 at Outlook Therapeutics, down from -$421131.0 in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$421131.0 in Q3 2025, with the low at -$1.2 million in Q4 2024.